"Medical device funding is hitting levels we haven't seen since 2021, with investors pouring billions into diagnostics and imaging companies. But while innovation has raced ahead, a fundamental problem still hasn't changed: critical medical hardware like MRI machines cost millions of dollars and is gatekept by large hospitals. So how do you take one of the most expensive, hospital-bound technologies and make it available anywhere?"
"Rebecca Bellan is a senior reporter at TechCrunch where she covers the business, policy, and emerging trends shaping artificial intelligence. Her work has also appeared in Forbes, Bloomberg, The Atlantic, The Daily Beast, and other publications. You can contact or verify outreach from Rebecca by emailing rebecca.bellan@techcrunch.com or via encrypted message at rebeccabellan.491 on Signal."
Medical device funding has returned to 2021 levels with billions flowing into diagnostics and imaging companies. Critical medical hardware such as MRI machines remains prohibitively expensive, often costing millions and concentrated in large hospitals. Chipiron, a Paris-based startup, is developing a lightweight MRI technology engineered for ease of installation and improved patient experience to enable imaging outside traditional hospital settings. The technology is intended to complement, not directly compete with, high-field superconducting MRI systems. Pursuing mergers and acquisitions is presented as an acceptable exit strategy within the medical industry. The approach targets decentralization of diagnostic imaging.
Read at TechCrunch
Unable to calculate read time
Collection
[
|
...
]